This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kazmierczak, B. Articles by Bullerdiek, J. Search for Related Content PubMed PubMed Citation Articles by Kazmierczak, B. Articles by Bullerdiek, J.

Molecular Characterization of 12q14–15 Rearrangements in Three Pulmonary Chondroid Hamartomas¹

Center for Human Genetics and Genetic Counselling, University of Bremen, Leobenerstrasse, ZHG, D-28359 Bremen, Germany [B. K., S. W., S. B., K. M-B., J. B.]; Center for Human Genetics, University of Leuven, Campus Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium [E. S., W. V. d. V.]; Urban Hospital St. Georg, Department of Pathology, Delitzscherstrasse 141, D-04129 Leipzig, Germany [R. H.]; and Hospital for Pulmonary Diseases, Department for Thorax Surgery, Karowerstrasse 14, D-13125 Berlin, Germany [K. U.]

Chromosomal aberrations involving the chromosomal breakpoint region 12q14–15 are frequently seen in a variety of mesenchymal tumors as uterine leiomyomas, lipomas, myxoid liposarcomas, enchondromas, or hemangiopericytomas. Therefore, this breakpoint region seems to be one of the most frequent chromosomal abnormality associated with the initiation of human mesenchymal neoplasms. To narrow down the breakpoint region on a molecular level in cells of three pulmonary chondroid hamartomas with 12q14–15 aberrations, we performed fluorescence in situ hybridization analysis with different cosmid clones originating from a YAC and cosmid contig overspanning parts of the region 12q14–15. We were able to narrow down the breakpoint to a region of 175 kb belonging to an area designated multiple aberration region because it also includes the breakpoints of leiomyomas, lipomas, and pleomorphic adenomas with 12q14–15 abnormalities. Our molecular and cytogenetic data suggest that hamartomas of the lung molecularly belong to the benign group of mesenchymal tumors showing multiple aberration region involvement.

¹ This work was supported by a grant from the Tönjes-Vagt-Stiftung and the Deutsche Forschungsgemeinschaft.

² To whom requests for reprints should be addressed.

Received 3/ 1/95. Accepted 4/27/95.

This article has been cited by other articles:

				A. R.J. Young and M. Narita Oncogenic HMGA2: short or small? Genes & Dev., May 1, 2007; 21(9): 1005 - 1009. [Full Text] [PDF]

				M. Fedele, S. Battista, G. Manfioletti, C. M. Croce, V. Giancotti, and A. Fusco Role of the high mobility group A proteins in human lipomas Carcinogenesis, October 1, 2001; 22(10): 1583 - 1591. [Abstract] [Full Text] [PDF]

				S. Battista, V. Fidanza, M. Fedele, A. J. P. Klein-Szanto, E. Outwater, H. Brunner, M. Santoro, C. M. Croce, and A. Fusco The Expression of a Truncated HMGI-C Gene Induces Gigantism Associated with Lipomatosis Cancer Res., October 1, 1999; 59(19): 4793 - 4797. [Abstract] [Full Text] [PDF]

				J. Goetz, B. Chatton, M.-G. Mattei, and C. Kedinger Structure and Expression of the ATFa Gene J. Biol. Chem., November 22, 1996; 271(47): 29589 - 29598. [Abstract] [Full Text] [PDF]

				P. Arlotta, A. K.-F. Tai, G. Manfioletti, C. Clifford, G. Jay, and S. J. Ono Transgenic Mice Expressing a Truncated Form of the High Mobility Group I-C Protein Develop Adiposity and an Abnormally High Prevalence of Lipomas J. Biol. Chem., May 5, 2000; 275(19): 14394 - 14400. [Abstract] [Full Text] [PDF]